Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Apremilast Use and Effectiveness Over a One Year Treatment Period in Patients With Psoriasis in The Netherlands

NCT02652494 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02652494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Apremilast Use and Effectiveness Over a One Year Treatment Period in Patients With Psoriasis in The Netherlands
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
February 22, 2016
Completion date
June 30, 2020
Enrollment
154 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis